Dr. Kanakry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Johns Hopkins Hospital
600 N Wolfe Street
Baltimore, MD 21287Phone+1 410-955-5000- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013- Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
Duke University School of MedicineClass of 2007
Certifications & Licensure
MD State Medical License 2010 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies Start of enrollment: 2021 Sep 23
Roles: Principal Investigator, Contact
- Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies Start of enrollment: 2022 May 23
Roles: Contact, Principal Investigator
- Optimizing PTCy Dose and Timing Start of enrollment: 2019 Jul 09
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.Abid, M. B., Hemant S Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V Michelis, Taiga Nishihori, Mrinal Pat...> ;Blood Advances. 2023 Nov 28
- 1 citationsEffect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age.Rima M Saliba, Christopher G Kanakry, Shahinaz Gadalla, Partow Kebriaei, Katayoun Rezvani, Richard E Champlin, Elizabeth J Shpall, Daniel Weisdorf, Rohtesh S Mehta> ;American Journal of Hematology. 2024 Jan 1
- HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.Abid, M. B., Rupa Narayan, Abhishek Niroula, Tao Wang, Michelle Kuxhausen, Meilun He, Everett Meyer, Yi-Bin Chen, Vijaya Raj Bhatt, Amer Beitinjaneh, Taiga Nishihori, ...> ;Transplantation and Cellular Therapy. 2023 Jul 1
- Join now to see all
Press Mentions
Drug Regimen Enough to Control Immune Disease After Some Bone Marrow TransplantsOctober 8th, 2014- How Common Chemo Drug Thwarts Graft Rejection in Bone Marrow TransplantsNovember 13th, 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
